Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -33.30%19.36M | -5.81%24.59M | -31.11%22.85M | 5.58%117.08M | -3.31%28.77M | 18.92%29.02M | -4.42%26.11M | 12.78%33.18M | 20.42%110.89M | 49.61%29.76M |
| Cost of revenue | -47.84%15.93M | -18.65%21.23M | -36.34%19.73M | 4.38%112.74M | -13.35%25.11M | 28.26%30.54M | -1.62%26.1M | 8.95%30.99M | 21.27%108.01M | 30.00%28.98M |
| Gross profit | 326.68%3.43M | 67,060.00%3.36M | 42.89%3.13M | 50.39%4.34M | 371.17%3.66M | -354.03%-1.51M | -99.36%5K | 124.77%2.19M | -4.57%2.89M | 132.34%777K |
| Operating expense | -21.27%2.51M | -11.65%2.39M | -12.39%2.3M | 3.57%10.26M | -23.15%2.04M | 30.45%3.19M | 9.52%2.7M | 6.67%2.62M | 11.60%9.91M | 52.90%2.65M |
| Selling and administrative expenses | ---- | ---- | ---- | 3.57%10.26M | ---- | ---- | ---- | ---- | 11.60%9.91M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 3.57%10.26M | ---- | ---- | ---- | ---- | 11.60%9.91M | ---- |
| Other operating expenses | -21.27%2.51M | -11.65%2.39M | -12.39%2.3M | 3.57%10.26M | -23.15%2.04M | 30.45%3.19M | 9.52%2.7M | 6.67%2.62M | --9.91M | --2.65M |
| Operating profit | 119.63%923K | 135.95%970K | 289.02%826K | 15.66%-5.92M | 186.91%1.63M | -154.52%-4.7M | -60.12%-2.7M | 70.61%-437K | -19.95%-7.02M | 54.74%-1.87M |
| Net non-operating interest income (expenses) | 15.42%-905K | 4.70%-892K | -0.33%-905K | -11.33%-4.19M | -21.91%-1.21M | -14.68%-1.07M | -12.10%-936K | 9.53%-902K | -48.58%-3.76M | -335.50%-995K |
| Non-operating interest expense | -15.42%905K | -4.70%892K | 0.33%905K | 11.33%4.19M | 21.91%1.21M | 14.68%1.07M | 12.10%936K | -9.53%902K | 48.58%3.76M | 335.50%995K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 15,300.00%308K | -32,000.00%-642K | 3,409.09%364K | 209.86%539.43K | 55,200.00%551K | 100.00%2K | 98.73%-2K | 96.69%-11K | 54.84%-491.03K | 99.66%-1K |
| Special income (charges) | 0 | 0 | ||||||||
| Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | -83.87%55K | 77.79%-313K | -246.42%-429K | -528.29%-1.24M | 90.81%-250K | 112.88%341K | -127.69%-1.41M | -53.64%293K | 113.87%289.9K | -29.72%-2.72M |
| Income before tax | 107.02%381K | 82.62%-877K | 86.38%-144K | 1.57%-10.81M | 112.78%714K | -0.04%-5.43M | -309.25%-5.05M | 51.60%-1.06M | 5.01%-10.98M | 17.27%-5.59M |
| Income tax | -11.22%87K | 6.10%87K | 5.10%103K | 2.78%412.49K | -5.07%131K | 28.95%98K | 9.33%82K | -13.27%98K | 125.82%401.34K | 111.56%138K |
| Net income | 105.32%294K | 81.20%-964K | 78.61%-247K | 1.42%-11.22M | 110.19%583K | -0.44%-5.53M | -319.48%-5.13M | 49.72%-1.16M | -13.76%-11.39M | -2.97%-5.72M |
| Net income continuous operations | 105.32%294K | 81.20%-964K | 78.61%-247K | 1.42%-11.22M | 110.19%583K | -0.44%-5.53M | -319.48%-5.13M | 49.72%-1.16M | -13.76%-11.39M | -2.97%-5.72M |
| Noncontrolling interests | -265.22%-76K | -305.71%-142K | -560.71%-129K | 88.25%-202.99K | 110.29%46K | 103.87%46K | -250.00%-35K | 158.33%28K | -3,368.90%-1.73M | -3,387.01%-447K |
| Net income attributable to the company | 106.64%370K | 83.86%-822K | 90.03%-118K | -14.12%-11.02M | 110.18%537K | -29.22%-5.57M | -317.05%-5.09M | 47.40%-1.18M | 3.03%-9.66M | 4.85%-5.28M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 106.64%370K | 83.86%-822K | 90.03%-118K | -14.12%-11.02M | 110.18%537K | -29.22%-5.57M | -317.05%-5.09M | 47.40%-1.18M | 3.03%-9.66M | 4.85%-5.28M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 106.90%0.0004 | 84.91%-0.0008 | 91.67%-0.0001 | -13.86%-0.0115 | 109.09%0.0005 | -28.89%-0.0058 | -320.83%-0.0053 | 47.83%-0.0012 | 10.62%-0.0101 | 12.70%-0.0055 |
| Diluted earnings per share | 106.90%0.0004 | 84.91%-0.0008 | 91.67%-0.0001 | -13.86%-0.0115 | 109.09%0.0005 | -28.89%-0.0058 | -320.83%-0.0053 | 47.83%-0.0012 | 10.62%-0.0101 | 12.70%-0.0055 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.